CRVS: Corvus Pharmaceuticals, Inc. Stock

by  •  • Comments Off on CRVS: Corvus Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 215.99
Enterprise Value ($M) 207.25
Book Value ($M) 32.57
Book Value / Share 0.48
Price / Book 6.63
NCAV ($M) 18.07
NCAV / Share 0.27
Price / NCAV 11.95

Profitability (mra)
Return on Invested Capital (ROIC) -1.85
Return on Assets (ROA) -1.55
Return on Equity (ROE) -1.87

Liquidity (mrq)
Quick Ratio 1.54
Current Ratio 1.54

Balance Sheet (mrq) ($M)
Current Assets 54.41
Assets 68.91
Liabilities 36.34
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -27.55
Net Income -62.29
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -25.42
Cash from Investing -27.48
Cash from Financing 49.03

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Samlyn Capital, Llc 9.80 6.44
02-13 13G/A Miller Richard A Md 7.70 41.70
05-09 13G Point72 Asset Management, L.P. 9.90
05-08 13D/A Orbimed Advisors Llc 11.10 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-02 149,243 827,659 18.03
2025-04-01 222,091 816,117 27.21
2025-03-31 240,625 815,996 29.49
2025-03-28 96,336 590,398 16.32

(click for more detail)

Similar Companies
CRMD – CorMedix Inc. CRON – Cronos Group Inc.
CRSP – CRISPR Therapeutics AG CURR – CURRENC Group Inc.
CVAC – CureVac N.V.


Financial data and stock pages provided by
Fintel.io